Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib von Yu, J, Chen, L, Cui, B, Wu, Christina, Choi, M Y, Chen, Y, Zhang, L, Rassenti, L Z, Widhopf II, G F, Kipps, T J

Volltext

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia von Rawstron, A C, Villamor, N, Ritgen, M, Böttcher, S, Ghia, P, Zehnder, J L, Lozanski, G, Colomer, D, Moreno, C, Geuna, M, Evans, P A S, Natkunam, Y, Coutre, S E, Avery, E D, Rassenti, L Z, Kipps, T J, Caligaris-Cappio, F, Kneba, M, Byrd, J C, Hallek, M J, Montserrat, E, Hillmen, P

Volltext

Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells von Hasan, M K, Yu, J, Chen, L, Cui, Bing, Widhopf II, G F, Rassenti, L, Shen, Z, Briggs, S P, Kipps, T J

Volltext

Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells von Yu, J, Chen, L, Chen, Y, Hasan, M K, Ghia, E M, Zhang, L, Wu, R, Rassenti, L Z, Widhopf, G F, Shen, Z, Briggs, S P, Kipps, T J

Volltext

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia von Murphy, E J, Neuberg, D S, Rassenti, L Z, Hayes, G, Redd, R, Emson, C, Li, K, Brown, J R, Wierda, W G, Turner, S, Greaves, A W, Zent, C S, Byrd, J C, McConnel, C, Barrientos, J, Kay, N, Hellerstein, M K, Chiorazzi, N, Kipps, T J, Rai, K R

Volltext

ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia von Rassenti, Laura Z, Huynh, Lang, Toy, Tracy L, Chen, Liguang, Keating, Michael J, Gribben, John G, Neuberg, Donna S, Flinn, Ian W, Rai, Kanti R, Byrd, John C, Kay, Neil E, Greaves, Andrew, Weiss, Arthur, Kipps, Thomas J

Volltext

Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia von Castro, J E, James, D F, Sandoval-Sus, J D, Jain, S, Bole, J, Rassenti, L, Kipps, T J

Volltext

Trisomy 12 CLLs progress through NOTCH1 mutations von Balatti, V, Lerner, S, Rizzotto, L, Rassenti, L Z, Bottoni, A, Palamarchuk, A, Cascione, L, Alder, H, Keating, M J, Kipps, T J, Pekarsky, Y, Croce, C M

Volltext

Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia von Veronese, A, Pepe, F, Chiacchia, J, Pagotto, S, Lanuti, P, Veschi, S, Di Marco, M, D'Argenio, A, Innocenti, I, Vannata, B, Autore, F, Marchisio, M, Wernicke, D, Verginelli, F, Leone, G, Rassenti, L Z, Kipps, T J, Mariani-Costantini, R, Laurenti, L, Croce, C M, Visone, R

Volltext

Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL von Lanasa, M C, Allgood, S D, Slager, S L, Dave, S S, Love, C, Marti, G E, Kay, N E, Hanson, C A, Rabe, K G, Achenbach, S J, Goldin, L R, Camp, N J, Goodman, B K, Vachon, C M, Spector, L G, Rassenti, L Z, Leis, J F, Gockerman, J P, Strom, S S, Call, T G, Glenn, M, Cerhan, J R, Levesque, M C, Weinberg, J B, Caporaso, N E

Volltext

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors von Fais, F, Ghiotto, F, Hashimoto, S, Sellars, B, Valetto, A, Allen, S L, Schulman, P, Vinciguerra, V P, Rai, K, Rassenti, L Z, Kipps, T J, Dighiero, G, Schroeder, Jr, H W, Ferrarini, M, Chiorazzi, N

Volltext

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia von Castro, J E, Sandoval-Sus, J D, Bole, J, Rassenti, L, Kipps, T J

Volltext

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia von Rosenwald, A, Alizadeh, A A, Widhopf, G, Simon, R, Davis, R E, Yu, X, Yang, L, Pickeral, O K, Rassenti, L Z, Powell, J, Botstein, D, Byrd, J C, Grever, M R, Cheson, B D, Chiorazzi, N, Wilson, W H, Kipps, T J, Brown, P O, Staudt, L M

Volltext

Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia von Schwaederlé, M, Ghia, E, Rassenti, L Z, Obara, M, Dell' Aquila, M L, Fecteau, J F, Kipps, T J

Volltext

Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia von MOTTA, M, RASSENTI, L, SHELVIN, B. J, LERNER, S, KIPPS, T. J, KEATING, M. J, WIERDA, W. G

Volltext

Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia von Steininger, C., Rassenti, L. Z., Vanura, K., Eigenberger, K., Jäger, U., Kipps, T. J., Mannhalter, C., Stilgenbauer, S., Popow-Kraupp, T.

Volltext

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia von Wierda, William G., Cantwell, Mark J., Woods, Sandra J., Rassenti, Laura Z., Prussak, Charles E., Kipps, Thomas J.

Volltext

Lack of allelic exclusion in B cell chronic lymphocytic leukemia von Rassenti, L Z, Kipps, T J

Volltext

Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development von Smith, E N, Ghia, E M, DeBoever, C M, Rassenti, L Z, Jepsen, K, Yoon, K-A, Matsui, H, Rozenzhak, S, Alakus, H, Shepard, P J, Dai, Y, Khosroheidari, M, Bina, M, Gunderson, K L, Messer, K, Muthuswamy, L, Hudson, T J, Harismendy, O, Barrett, C L, Jamieson, C H M, Carson, D A, Kipps, T J, Frazer, K A

Volltext

Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial von Bühler, A, Wendtner, C-M, Kipps, T J, Rassenti, L, Fraser, G A M, Michallet, A-S, Hillmen, P, Dürig, J, Gregory, S A, Kalaycio, M, Aurran-Schleinitz, T, Trentin, L, Gribben, J G, Chanan-Khan, A, Purse, B, Zhang, J, De Bedout, S, Mei, J, Hallek, M, Stilgenbauer, S

Volltext